New Frameworks to Assess Value of Cancer Care: Strengths and Limitations
about
Addressing Patients' Priorities as a Strategy to Improve Value.The ESMO-Magnitude of Clinical Benefit Scale for novel oncology drugs: correspondence with three years of reimbursement decisions in Israel.Evaluating Frameworks That Provide Value Measures for Health Care Interventions.Value: The Next Frontier in Cancer Care.Early Steps in the Value of Cancer Care-Many Paths Remain Unexplored.Assessment of costs associated with adverse events in patients with cancer.
P2860
New Frameworks to Assess Value of Cancer Care: Strengths and Limitations
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New Frameworks to Assess Value of Cancer Care: Strengths and Limitations
@en
New Frameworks to Assess Value of Cancer Care: Strengths and Limitations.
@nl
type
label
New Frameworks to Assess Value of Cancer Care: Strengths and Limitations
@en
New Frameworks to Assess Value of Cancer Care: Strengths and Limitations.
@nl
prefLabel
New Frameworks to Assess Value of Cancer Care: Strengths and Limitations
@en
New Frameworks to Assess Value of Cancer Care: Strengths and Limitations.
@nl
P2860
P1433
P1476
New Frameworks to Assess Value of Cancer Care: Strengths and Limitations
@en
P2093
Alex Bastian
Lowell E Schnipper
P2860
P304
P356
10.1634/THEONCOLOGIST.2016-0177
P577
2016-05-31T00:00:00Z